Occult central nervous system (CNS) involvement in patients (pts.) with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.

被引：0
|
作者：
Miller, KD
Weathers, T
Haney, LG
Timmerman, R
Dickler, M
Shen, J
Sledge, GW
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
214
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] Prognostic impact of body mass index (BMI) on overall survival in patients with metastatic breast cancer
    Saleh, K.
    Carton, M.
    Dieras, V. C.
    Heudel, P. -E.
    Brain, E.
    Firmin, N.
    Mailliez, A.
    Patsouris, A.
    Reynier, M. A. Mouret
    Goncalves, A.
    Ferrero, J. -M.
    Petit, T.
    Levy, C.
    Uwer, L.
    Cottu, P. H.
    Veron, L.
    Deluche, E.
    Savignoni, A.
    Robain, M.
    Delaloge, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [32] Meningism as a poor risk factor in breast cancer patients with relapse in central nervous system (CNS)
    Jesus Schwarz, Luis
    Vallejos, Carlos S.
    Neciosup, Silvia P.
    Pinto, Joseph
    Vidaurre, Tatiana
    Ferreyros, Greenlandia
    Leonidas Gomez, Henry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab
    Montagna, E.
    Cancello, G.
    D'Agostino, D.
    Lauria, R.
    Forestieri, V.
    Esposito, A.
    Silvestro, L.
    Accurso, A.
    Placido, S. De
    Laurentiis, M. De
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 275 - 280
  • [34] Central nervous system involvement in non-Hodgkin's lymphoma: A single-center analysis of prognostic factors for survival.
    Korfel, A
    Jahnke, K
    Martus, P
    Schwartz, S
    Fischer, L
    Stein, H
    Thiel, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 613S - 613S
  • [35] Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab
    E. Montagna
    G. Cancello
    D. D’Agostino
    R. Lauria
    V. Forestieri
    A. Esposito
    L. Silvestro
    A. Accurso
    S. De Placido
    M. De Laurentiis
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 275 - 280
  • [36] Impact of extracranial disease status on survival after initial central nervous system (CNS) involvement and radiation therapy in HER2+breast cancer brain metastases (BCBM).
    Noteware, Laura
    Ramirez, Luis
    Dalal, Nicole
    Herndon, James Emmett
    Floyd, Scott R.
    Van Swearingen, Amanda E. D.
    Anders, Carey K.
    Sammons, Sarah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] METASTATIC CENTRAL NERVOUS SYSTEM RECURRENCE IN BREAST CANCER: IMPACT OF TUMOUR SUB-TYPE
    O'Carrigan, Brent
    Chan, Arlene
    McGregor, Scott
    Beith, Jane
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 114 - 114
  • [38] Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases
    Alvarado-Miranda, A.
    Cabrera-Galeana, P.
    Munoz-Montano, W. R.
    Lara-Medina, F.
    Bargallo-Rocha, E.
    Arrieta-Rodriguez, O.
    Perez, M.
    Porras-Reyes, F.
    Mohar-Betancourt, A.
    Gamboa, C.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [39] High incidence of central nervous system (CNS) metastases in patients (pts) treated with upfront epidoxorubicin (E) and docetaxel (D) for advanced breast cancer (ABC).
    Crivellari, D
    Pagani, O
    Matinelli, G
    Nolè, F
    Veronesi, A
    Lombardi, D
    Graffeo, R
    Hesse, D
    Thürlimann, B
    Borner, M
    Bauer, J
    Sessa, C
    Goldhirsch, A
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 29 - 29
  • [40] Signs and symptoms at central nervous system (CNS) relapse in breast cancer patients with Leptomeningeal carcinomatosis related with shorter survival after recurrence
    Gomez, H. L.
    Schwarz, L. J.
    Vasquez, J.
    Neciosup, S. P.
    Pinto, J. A.
    Vidaurre, T.
    Ferreyros, G.
    Vallejos, C. S.
    [J]. CANCER RESEARCH, 2012, 72
12345